What they were paid
Emergent BioSolutions Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $100,000 | $250,000 | $0 | $0 | $350,000 |
| FY2024 | $100,000 | $175,000 | — | — | $275,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Emergent BioSolutions Inc. DEF 14A filed March 20, 2026, accession 0001367644-26-000033, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Emergent BioSolutions pays directors a $70,000 cash retainer and $250,000 in 75% RSUs and 25% stock options.
Committees
FY2025 · as the proxy prints themAudit · Compensation · Nominating/Governance
The rest of the Emergent BioSolutions board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Donald DeGolyer | Independent Director | $338,556 |
| John Fowler Jr | Independent Director | $0 |
| Joseph Papa | Director | $0 |
| Kathryn Zoon, Ph.D | Independent Director | $360,000 |
| Keith Katkin | Independent Director | $350,000 |
| Marvin White | Independent Director | $360,000 |
| Neal Fowler | Independent Director | $345,000 |
| Sujata Dayal | Independent Director | $348,750 |
| Zsolt Harsanyi, Ph.D | Chair of the Board | $495,000 |
The full Emergent BioSolutions compensation record
free company briefThis page is one director within Emergent BioSolutions's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat